Darwin Global Management, Ltd. — Q3 2023 13F-HR

← Darwin Global Management, Ltd.

Q3 2023 · 13F-HR

Darwin Global Management, Ltd.holdings as filed

Filed 2023-11-14 · accession 0001892688-23-000097

$284.2M

Reported value

Positions

2023-09-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
02290A102	—	AMBRX BIOPHARMA INC	$191.9M	67.5%	16,688,636	Common	SOLE
45258J102	IMVT	IMMUNOVANT INC	$69.8M	24.6%	1,818,371	Common	SOLE
04016X101	ARGX	ARGENX SE	$22.4M	7.89%	45,615	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.